EDGAR Filing Documents for 0001193125-04-033201

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-04-033201

Filing Date

2004-03-03

Accepted

2004-03-02 19:09:33

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT 3 TO REGISTRATION STATEMENT FORM S-1	ds1a.htm	S-1/A	1776128
3	WARRANT TO PURCHASE SERIES F PREFERRED STOCK IN FAVOR OF OXFORD FINANCE CORP	dex1020.htm	EX-10.20	59704
4	COLLABORATION AGREEMENT WITH FRESENIUS BIOTECH GMBH, DATED NOVEMBER 14, 2003	dex1048.htm	EX-10.48	253838
5	CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS	dex231.htm	EX-23.1	2653
7	GRAPHIC	g26071g14o31.jpg	GRAPHIC	119538
8	GRAPHIC	g26071g68b48.jpg	GRAPHIC	104138
9	GRAPHIC	g26071g85j06.jpg	GRAPHIC	35214
10	GRAPHIC	g26071g93g78.jpg	GRAPHIC	114916
11	GRAPHIC	g26071g99y74.jpg	GRAPHIC	27368
	Complete submission text file	0001193125-04-033201.txt		2495931

Mailing Address

Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200

XCYTE THERAPIES INC (Filer) CIK: 0001130166 (see all company filings)